TAG:
laboratory industry
Ex-IMPATH Executives Face Criminal Charges
By Robert Michel | From the Volume XII No. 6 – April 18, 2005 Issue
CEO SUMMARY: With the announcement by Federal prosecutors of criminal and civil actions against a total of seven ex-IMPATH executives, IMPATH becomes the laboratory industry’s worst criminal scandal. Federal prosecutors contend these executives, during their employment at IMPATH, engine…
“April 18, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 6 – April 18, 2005 Issue
This may be one of the laboratory industry’s biggest “oops” ever! As part of a laboratory proficiency testing pro- gram, 4,000 laboratories in 18 countries were sent live samples of the H2N2 flu virus. In 1957, H2N2 is believed to have caused between one and four million deaths. Last week, the …
Phlebotomist Convicted For Theft of Patient ID
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
CEO SUMMARY: Patient identity theft by a phlebotomist, prosecuted and convicted under HIPAA. This is a story whose true dimensions went unreported within the laboratory industry—until now! THE DARK REPORT is first to alert its clients to the possibility that every laboratory and patholo…
Spectrum Owns MEDex, Comments on Trends
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Spectrum Laboratory Network recently completed its acquisition of MEDex Laboratories, Inc. of Kingsport, Tennessee. It is becoming a regional laboratory powerhouse, challenging Laboratory Corporation of America in North Carolina and establishing a sales base in Atlanta, long-…
Five Lab Acquisitions Over the Past Ten Weeks
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Many lab executives and pathologists will be surprised to learn that five independent laboratory companies were acquired between December 1, 2004 and February 11, 2005. Only one acquisition was announced to the public. The other four were private sales and both buyers and sel…
Doctor “Pay to Perform” Launched by Medicare
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Medicare’s just-announced physician “pay-for-performance” program will be a positive development for laboratories and pathologists. One consequence is that physicians will be measured on how effectively they use recommended lab tests in certain areas of care. This will …
“February 14, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
There’s a new leader at the Clinical Laboratory Management Association (CLMA). On February 7, 2005, CLMA President Judy Lien announced that the association’s new Chief Executive Officer is Dana Procsal, Ph.D., a veteran laboratory industry executive. Most recently, Procsal was V…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
Government Health Contracting Has a Seamy Side
By R. Lewis Dark | From the Volume XII No. 1 – January 3, 2005 Issue
WHAT MIGHT HAPPEN TO YOUR LABORATORY if either or both Medicare and your state’s Medicaid program initiated some type of competitive bidding for laboratory testing services? I’ll bet there would be a level of financial pain, not to mention the consequences to physicians and patients as long-stan…
More Lab Consolidation: LabCorp Buys US LABS
By Robert Michel | From the Volume XII No. 1 – January 3, 2005 Issue
CEO SUMMARY: Following three years of rapid growth in specimen volume and revenues, US LABS has accepted a purchase offer from Laboratory Corporation of America. Both US LABS’ fast growth and its sale to a national lab demonstrate that there is still opportunity in laboratory testing—…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized